Menu Search
Equities

Somnomed Ltd

SOM:ASX

Somnomed Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.29
  • Today's Change0.00 / 0.00%
  • Shares traded24.43k
  • 1 Year change-18.54%
  • Beta1.5701
Data delayed at least 20 minutes, as of Nov 14 2024 23:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Somnomed Ltd had net income fall 53.04% from a loss of 8.00m to a larger loss of 12.24m despite a 9.64% increase in revenues from 83.62m to 91.68m. An increase in the selling, general and administrative costs as a percentage of sales from 60.84% to 62.91% was a component in the falling net income despite rising revenues.
Gross margin60.17%
Net profit margin-13.35%
Operating margin-12.29%
Return on assets-18.51%
Return on equity-36.31%
Return on investment-26.05%
More ▼

Cash flow in AUDView more

In 2024, Somnomed Ltd increased its cash reserves by 35.32%, or 4.22m. Cash Flow from Financing totalled 16.68m or 18.19% of revenues. In addition the company used 6.33m for operations while cash used for investing totalled 5.34m.
Cash flow per share-0.0536
Price/Cash flow per share--
Book value per share0.3376
Tangible book value per share0.1853
More ▼

Balance sheet in AUDView more

Somnomed Ltd has a Debt to Total Capital ratio of 12.99%, a lower figure than the previous year's 93.47%.
Current ratio1.76
Quick ratio1.45
Total debt/total equity0.1493
Total debt/total capital0.1299
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.